No-Needle glucose monitor could spot pregnancy risks early
NCT ID NCT04979312
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study is testing a device called LabClasp that measures blood sugar without needles. Researchers want to see if regular, non-invasive glucose checks can help predict gestational diabetes and preeclampsia in pregnant women. The study plans to enroll 100 women with at least one risk factor for gestational diabetes, but it is currently suspended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LabClasp (non-invasive glucose monitoring device)
- What this could lead to
- If successful, this could lead to a simple, needle-free way to predict gestational diabetes and preeclampsia early in pregnancy.
- What could go wrong
- This is a small pilot study (100 participants) that is currently suspended, so results are uncertain. The device's accuracy and real-world usefulness are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55901, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal implant may tackle pain and blood pressure together
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes
- Wearable tech could stop Post-Pregnancy diabetes in its tracks
- Could oxidative stress be the hidden culprit behind blood vessel damage after gestational diabetes?
- Blood vessel damage after gestational diabetes: is a rogue enzyme to blame?
- Wrist-Worn blood pressure monitor put to the test against gold standard